Table 3 Urinary symptoms pre-operatively, 6-months and 1-year following TAH, NDVH and TLH

Urinary flow symptoms pre-op [median, (IQ1-IQ3)]

2 (1–4)

3 (2–5)

1 (1–4)

p = 0.14

Urinary flow symptoms 6-months [median (IQ1-IQ3)]

1 (0–3), p < 0.001^#

2 (0–4.75), p < 0.001^#

1 (0–3), p < 0.01^#

Urinary flow symptoms 1-year [median (IQ1-IQ3)]

1 (0–3), p < 0.001^#

2 (0.5–4), p < 0.001^#

1 (0–3), p < 0.05^#

Urinary voiding symptoms pre-op [median, (IQ1-IQ3)]

0 (0–0)

0 (0–1)

0 (0–0)

p = 0.25

Urinary voiding symptoms 6-months [median (IQ1-IQ3)]

0 (0–0), p = 0.47^#

0 (0–0.75), p < 0.05^#

0 (0–0), p = 0.47^#

Urinary voiding symptoms 1-year [median (IQ1-IQ3)]

0 (0–0), p = 0.20^#

0 (0–1), p < 0.05^#

0 (0–0), p < 0.05^#

Urinary incontinence pre-op [median, (IQ1-IQ3)]symptoms

0 (0–2)

0 (0–3)

0 (0–3)

p = 0.25

Urinary incontinence symptoms 6-months [median (IQ1-IQ3)]

0 (0–2), p = 0.06^#

1 (0.75–3), p = 0.07^#

0 (0–1.75), p = 0.21^#

Urinary incontinence symptoms 1-year [median (IQ1-IQ3)]

0 (0–2), p < 0.01^#

0 (0–3), p < 0.01^#

0 (0–2), p < 0.05^#